Thursday, February 13, 2025
3:00PM – 4:00PM ET
Please note this virtual program is 3:00PM Eastern, 2:00PM Central, 1:00PM Mountain and 12:00PM Pacific.
PROGRAM CHAIR & FACULTY
Charles W. Hoge, MD., COL(Ret) U.S. Army |
PROGRAM OVERVIEW
This series focuses on understanding and treating Post-Traumatic Stress Disorder (PTSD), with a special emphasis on veterans. Participants will explore the burden and epidemiology of PTSD, the neurobiology underlying the disorder, and current treatment approaches, including pharmacological and psychotherapeutic options. The program will also cover best practices for using validated screening tools and trauma-informed care in clinical evaluations. Additionally, it will review clinical guidelines and emerging therapies for PTSD, equipping clinicians with the knowledge to provide effective, evidence-based care.
TARGET AUDIENCE
The intended audience includes US-based HCPs in the Veterans Health Administration involved in the care of Veteran patients with post-traumatic stress disorder (PTSD), including primary care clinicians, psychiatrists, and obstetricians/gynecologists.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Examine the burden and epidemiology of post-traumatic stress disorder (PTSD), with particular focus on PTSD in veterans
- Outline PTSD neurobiology and hypothesized mechanisms underlying treatment approaches (pharmacological and therapeutic)
- Apply best practices for using validated screening tools in assessment of PTSD and trauma-informed approaches to the clinical evaluation of PTSD in primary and specialty care
- Assess evidence and clinical practice guidelines regarding the use of both pharmacologic and psychotherapeutic treatments for PTSD, including emerging and investigational therapies
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]